`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`COALITION FOR AFFORDABLE DRUGS X LLC,
`Petitioner,
`
`VI
`
`ANACOR PHARMACEUTICALS, INC.,
`Patent Owner.
`
`Case No. IPR2015—01776
`
`Patent No. 7,582,621
`
`PATENT OWNER’S MOTION FOR ADMISSION PRO HAC VICE OF
`
`JEFFREY B. ELIKAN UNDER 37 C.F.R. § 42.10
`
`
`
`IPR2015~O1776
`
`1.
`
`Relief Requested
`
`Pursuant to 37 C.F.R. § 42.10, and in accordance with the Board’s Order,
`
`Paper No. 7 in Case IPR2013-00639, and the Notice of Filing Date Accorded to
`
`Petition (Paper No. 4), Patent Owner requests that the Board admit Jeffrey B.
`
`Elikan pro hac vice in this proceeding.
`
`II.
`
`Statement of Facts
`
`37 C.F.R. §42.l0(c) states that the Board “may recognize counsel pro hac
`
`vice during a proceeding upon a showing of good cause, subject to the condition
`
`that lead counsel be a registered practitioner and to any other conditions as the
`
`Board may impose.
`
`For example, where the lead counsel
`
`is a registered
`
`practitioner, a motion to appear pro hac vice by counsel who is not a registered
`
`practitioner may be granted upon showing that counsel is an experienced litigating
`
`attorney and has an established familiarity with the subject matter at issue in the
`
`proceeding. The facts, supported by the attached Declaration of Jeffrey B. Elikan
`
`in Support of Patent Owner’s Motion for Admission Pro Hac Vice (“Elikan
`
`Declaration”), establish good cause to admit Mr. Elikan pro hac vice in this
`
`proceeding.
`
`1.
`
`2.
`
`Lead counsel, Andrea G. Reister, is a registered practitioner.
`
`Counsel, Jeffrey B. Elikan, is an experienced litigating attorney in his
`
`twenty—fifth year of law practice. Elikan Decl. at 119. Mr. Elikan has been
`
`
`
`IPR20 15-01776
`
`litigating patent cases since approximately 1997 and has served as trial counsel in
`
`over thirty patent infringement cases. Id. Mr. Elikan is a member in good standing
`
`of the New York State Bar and the District of Columbia Bar. Id. at 11 2. He is also
`
`admitted to practice in the United States Court of Appeals for the Federal Circuit,
`
`the United States District Court for the District of Maryland, the United States
`
`District Court for Southern District of New York, and the United States District
`
`Court of the Eastern District of New York. Id.
`
`3.
`
`Mr. Elikan has familiarity with the subject matter and patent at issue
`
`in this proceeding, U.S. Patent No. 7,582,621 (“the ’62l Patent”), including its
`
`prosecution history, the related U.S. Patent No. 7,767,657, and the scientific field
`
`to which the ’62l Patent is addressed.
`
`Id. at il 10. Mr. Elikan has worked with
`
`Anacor Pharmaceuticals, Inc.,
`
`the Patent Owner in this proceeding, and lead
`
`counsel
`
`to develop the responses to Petitioner’s invalidity challenges.
`
`Id.
`
`Specifically, Mr. Elikan was involved with retaining experts and working with
`
`those experts, whose declarations support the Patent Owner Response.
`
`Id. Mr.
`
`Elikan was also involved in developing the strategy relating to Anacor’s Patent
`
`Owner Response.
`
`Id. All of the above activities required developing a thorough
`
`understanding of the patent at issue in this proceeding,
`
`the prior art, and the
`
`relevant scientific field. Id.
`
`
`
`IPR2015—01776
`
`4.
`
`Mr. Elikan has read and will comply with the Office Patent Trial
`
`Guide and the Board’s Rules for Practice for Trials set forth in Part 42 of the
`
`C.F.R., and he agrees to be subject to the USPTO Rules of Professional Conduct
`
`set forth in 37 C.F.R. §§ 11.100 et seq. and disciplinary jurisdiction under 37
`
`C.F.R. § 1l.19(a).
`
`Id. at W 6——7. Mr. Elikan has not previously applied to appear
`
`pro hac vice in any other proceedings before the Office, although he is
`
`contemporaneously submitting pro hac vice applications on behalf of Patent
`
`Owner in the co-pending proceedings IPR2015—01780 and IPR2015—01785. Id. at
`
`1l8.
`
`III. Analysis
`
`The facts contained in the Statement of Facts above, and contained in the
`
`Elikan Declaration, establish that there is good cause to admit Mr. Elikan pro hac
`
`vice in this proceeding, under 37 C.F.R. §42.10. Lead counsel is a registered
`
`practitioner, Mr. Elikan is an experienced litigating attorney, and Mr. Elikan has an
`
`established familiarity with the subject matter at issue in this proceeding.
`
`IV. Conclusion
`
`For the foregoing reasons, Patent Owner respectfully requests that the Board
`
`admit Jeffrey B. Elikan pro hac vice in this proceeding.
`
`
`
`Dated: June 20, 2016
`
`Respectfully submitted,
`
`IPR2015-01776
`
`,,Q so
`
`K
`);,/
`W
`
`,.»~«\
`\
`2
`
`,0
`
`‘
`
`Andrea G. Reiste{
`Registration No.2 36,253
`COVINGTON & BURLING LLP
`
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`(202) 662-6000
`Attorneys for Patent Owner
`
`
`
`CERTIFICATE OF SERVICE
`
`IPR2015—01776
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that on this 20th day of June 2016,
`
`the foregoing Patent Owner’s Motion for Admission Pro Hac Vice of Jeffrey B.
`
`Elikan Under 37 C.F.R. § 42.10 was served Via electronic mail by agreement of
`
`the parties, on the following counsel of record for petitioner.
`
`Jeffrey D. Blake
`Kathleen E. Ott
`
`Peter A. Gergely
`Ryan James Fletcher
`Brent E. Routman
`
`KerydinIPR@merchantgould.com
`Merchant & Gould PC
`
`A
`
`Dated: June 20, 2016
`
`
`
`j
`
`.
`
`,L«
`
`Andrea G. Reister, Esq.
`Registration No.: 36,253